177 related articles for article (PubMed ID: 34030153)
1. Availability of Sexually Transmitted Disease and HIV Clinical Services: Ending the HIV Epidemic Versus Non-Ending the HIV Epidemic Jurisdictions, 2018.
Leichliter JS; Cuffe KM; Kelley KR; Gift TL
Sex Transm Dis; 2022 Jan; 49(1):e13-e16. PubMed ID: 34030153
[TBL] [Abstract][Full Text] [Related]
2. Human Immunodeficiency Virus/Sexually Transmitted Infection Counseling and Testing Services Received by Gay and Bisexual Men Using Preexposure Prophylaxis at Their Last PrEP Care Visit.
Parsons JT; John SA; Whitfield THF; Cienfuegos-Szalay J; Grov C
Sex Transm Dis; 2018 Dec; 45(12):798-802. PubMed ID: 30422969
[TBL] [Abstract][Full Text] [Related]
3. Population and Individual-Level Effects of Human Immunodeficiency Virus Preexposure Prophylaxis on Sexually Transmitted Infection Epidemics Among Men Who Have Sex With Men.
Grey JA; Torrone EA; Sullivan PS; Weiss KM; Aral SO
Sex Transm Dis; 2019 Dec; 46(12):759-761. PubMed ID: 31764765
[No Abstract] [Full Text] [Related]
4. Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017.
Finlayson T; Cha S; Xia M; Trujillo L; Denson D; Prejean J; Kanny D; Wejnert C;
MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(27):597-603. PubMed ID: 31298662
[TBL] [Abstract][Full Text] [Related]
5. Sexually Transmitted Infection Testing and Prevalence Before and After Preexposure Prophylaxis Initiation Among Men Aged ≥18 Years in US Private Settings.
Tao G; Pearson WS; Sullivan JM; Henk HJ; Gift TL
Sex Transm Dis; 2021 Jul; 48(7):515-520. PubMed ID: 33633074
[TBL] [Abstract][Full Text] [Related]
6. Impact of Providing Preexposure Prophylaxis for Human Immunodeficiency Virus at Clinics for Sexually Transmitted Infections in Baltimore City: An Agent-based Model.
Kasaie P; Berry SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; Pennington J; German D; Flynn CP; Beyrer C; Dowdy DW
Sex Transm Dis; 2018 Dec; 45(12):791-797. PubMed ID: 29944642
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Pandemic, Pre-exposure Prophylaxis (PrEP) Care, and HIV/STI Testing Among Patients Receiving Care in Three HIV Epidemic Priority States.
Hill BJ; Anderson B; Lock L
AIDS Behav; 2021 May; 25(5):1361-1365. PubMed ID: 33599879
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of HIV pre-exposure prophylaxis counselling among non-Hispanic Black youth diagnosed with bacterial sexually transmitted infections in the United States, 2014-2019.
Watson DL; Shaw PA; Petsis DT; Pickel J; Bauermeister JA; Frank I; Wood SM; Gross R
J Int AIDS Soc; 2022 Feb; 25(2):e25867. PubMed ID: 35192740
[TBL] [Abstract][Full Text] [Related]
9. The Broader Context of "Ending the HIV Epidemic: A Plan for America" Initiative.
Kates J; Millett G; Dawson L; Honermann B; Jones A; Sherwood J; Garcia ZI; Kuenzle K
Am J Public Health; 2020 Jan; 110(1):58-60. PubMed ID: 31800281
[No Abstract] [Full Text] [Related]
10. Assessment for sexually transmitted infections in men who have sex with men attending a nurse-run HIV preexposure prophylaxis clinic.
Stockton JM
J Am Assoc Nurse Pract; 2021 Feb; 33(12):1290-1294. PubMed ID: 33625163
[TBL] [Abstract][Full Text] [Related]
11. Impact of the Early COVID-19 Pandemic on the Number of HIV Preexposure Prophylaxis Uses and the Proportion of Preexposure Prophylaxis Users Receiving Sexually Transmitted Infection Testing Services.
Schmidt MA; Salas SB; Donald JL; Gift TL; Tao G
Sex Transm Dis; 2023 May; 50(5):304-309. PubMed ID: 36730891
[TBL] [Abstract][Full Text] [Related]
12. Human Immunodeficiency Virus Preexposure Prophylaxis Knowledge, Attitudes and Perceptions of Sexual Health Risk in an Age of Sexually Transmitted Infection Antimicrobial Resistance.
Lorenc A; Nicholls J; Kesten JM; Macgregor L; Speare N; Harryman L; Turner KME; Horner P; Horwood J
Sex Transm Dis; 2021 Sep; 48(9):685-692. PubMed ID: 33534406
[TBL] [Abstract][Full Text] [Related]
13. Alignment of Ending the HIV Epidemic Priority Jurisdictions With Availability of HIV Service Organizations: An Ecological Study.
Webster JL; Rafalko N; Thorpe LE; Duncan DT; Gracely EJ; Goldstein ND
AIDS Educ Prev; 2023 Aug; 35(4):320-331. PubMed ID: 37535323
[TBL] [Abstract][Full Text] [Related]
14. Women Are Less Likely to Be Tested for HIV or Offered Preexposure Prophylaxis at the Time of Sexually Transmitted Infection Diagnosis.
Yumori C; Zucker J; Theodore D; Chang M; Carnevale C; Slowikowski J; LaSota E; Olender S; Gordon P; Cohall A; Sobieszczyk ME
Sex Transm Dis; 2021 Jan; 48(1):32-36. PubMed ID: 33315784
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated With Willingness to Use Daily Antibiotics as Sexually Transmitted Infection Prophylaxis Among HIV Preexposure Prophylaxis-Experienced Gay and Bisexual Men in Australia.
Arapali T; Grulich AE; Heywood AE; Chan C; Fraser D; Zablotska IB; Holt M; Vaccher SJ; Bavinton BR
Sex Transm Dis; 2023 Mar; 50(3):144-149. PubMed ID: 36730780
[TBL] [Abstract][Full Text] [Related]
16. Sexually transmitted infection testing and prevalence among MSM using event-based dosing HIV pre-exposure prophylaxis.
Simmons K; Fitzpatrick C; Richardson D
Sex Health; 2023 Apr; 20(2):177-179. PubMed ID: 36709761
[TBL] [Abstract][Full Text] [Related]
17. Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study.
Coyer L; Prins M; Davidovich U; van Bilsen WPH; Schim van der Loeff MF; Hoornenborg E; Matser A; Boyd A
AIDS Patient Care STDS; 2022 Jun; 36(6):208-218. PubMed ID: 35687814
[TBL] [Abstract][Full Text] [Related]
18. Sexually Transmitted Infection Testing, Prevalence, and Treatment Among Individuals Receiving HIV Preexposure Prophylaxis Within an Integrated Healthcare Delivery System.
Schmidt MA; Dickerson JF; O'Keeffe-Rosetti MC; Salas SB; Donald JL; Tao G
Sex Transm Dis; 2022 Sep; 49(9):616-621. PubMed ID: 35724111
[TBL] [Abstract][Full Text] [Related]
19. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
[TBL] [Abstract][Full Text] [Related]
20. Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis.
Tang EC; Vittinghoff E; Philip SS; Doblecki-Lewis S; Bacon O; Chege W; Coleman ME; Elion R; Buchbinder S; Kolber MA; Liu AY; Cohen SE
AIDS; 2020 Jul; 34(8):1181-1186. PubMed ID: 32205724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
